Astrana Health, Inc. (ASTH) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Astrana Health, Inc. (ASTH) Healthcare & Pipeline Overview

Astrana Health, Inc. is a physician-centric, technology-powered healthcare management company delivering medical care services in the U.S. through its integrated, value-based model. Operating across Care Partners, Care Delivery, and Care Enablement segments, Astrana Health leverages its proprietary platform to empower providers and coordinate patient care, primarily serving insured and non-insured patients.

What Is the Investment Thesis for ASTH?

Astrana Health presents a compelling case for investment due to its strategic focus on value-based care and technology-driven healthcare management. With a market capitalization of $1.92B and a P/E ratio of 62.6, the company demonstrates significant growth potential within the expanding healthcare services market. Key value drivers include the company's integrated care model, which enhances care coordination and outcomes, and its proprietary technology platform, which improves operational efficiency. Growth catalysts include expanding its network of providers and patients, penetrating new geographic markets, and capitalizing on the shift towards value-based care. However, investors should be aware of potential risks such as regulatory changes and competition in the healthcare industry.

Based on FMP financials and quantitative analysis

ASTH Key Highlights

Market capitalization of $1.92B, reflecting investor confidence in Astrana Health's growth potential.

• P/E ratio of 62.6, indicating a premium valuation based on earnings expectations.
• Gross margin of 6.8%, highlighting the need for improved cost management and operational efficiency.
• Profit margin of 0.9%, demonstrating the potential for increased profitability through strategic initiatives.
• Beta of 0.90, suggesting a slightly lower volatility compared to the overall market.

Who Are ASTH's Competitors?

ASTH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ASTH's Key Strengths?

Integrated care model

• Proprietary technology platform
• Focus on value-based care
• Experienced management team

What Are ASTH's Weaknesses?

Relatively small market share

• Limited geographic presence
• Dependence on key providers
• Low gross margin

What Could Drive ASTH Stock Higher?

Expansion into new geographic markets to broaden patient reach and revenue streams.

• Continued development and enhancement of the proprietary technology platform to improve care coordination and efficiency.
• Increasing participation in value-based care contracts to align incentives and drive cost savings.

What Are the Key Risks for ASTH?

Rich valuation — a P/E of 62.6 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.

• Regulatory changes in the healthcare industry could impact Astrana Health's operations and profitability.
• Increased competition from established healthcare providers and emerging technology companies could erode market share.
• Economic downturn could reduce patient demand for healthcare services and impact revenue.
• Cybersecurity risks could compromise patient data and disrupt operations.

What Are the Growth Opportunities for ASTH?

• Expanding Geographic Reach: Astrana Health has the opportunity to expand its geographic footprint by entering new markets and establishing partnerships with local healthcare providers. This expansion can be achieved through strategic acquisitions, joint ventures, or organic growth initiatives. The U.S. healthcare market is vast and fragmented, offering ample opportunities for Astrana Health to increase its market share and serve a larger patient population. Timeline: Ongoing.
• Enhancing Technology Platform: Astrana Health can further enhance its proprietary technology platform by incorporating advanced analytics, artificial intelligence, and machine learning capabilities. This will enable the company to improve care coordination, personalize treatment plans, and optimize operational efficiency. The market for healthcare technology is rapidly growing, driven by the increasing adoption of digital health solutions. Timeline: Ongoing.
• Increasing Value-Based Care Contracts: Astrana Health can increase its participation in value-based care contracts with health plans and government payers. This will align incentives with providers and reward them for delivering high-quality, cost-effective care. The shift towards value-based care is accelerating, driven by the need to control healthcare costs and improve patient outcomes. Timeline: Ongoing.
• Strengthening Provider Network: Astrana Health can strengthen its provider network by recruiting and retaining high-quality primary care physicians, specialists, and hospitalists. This will ensure that the company has the capacity to meet the growing demand for its services and deliver comprehensive care to its patients. The market for healthcare professionals is competitive, requiring Astrana Health to offer attractive compensation and benefits packages. Timeline: Ongoing.
• Developing New Service Offerings: Astrana Health can develop new service offerings, such as telehealth, remote patient monitoring, and chronic disease management programs. This will enable the company to expand its revenue streams and cater to the evolving needs of its patients. The market for digital health solutions is rapidly growing, driven by the increasing adoption of technology-enabled healthcare services. Timeline: Ongoing.

What Are ASTH's Competitive Advantages?

• Proprietary Technology Platform: Astrana Health's technology platform provides a competitive advantage by enabling efficient care coordination and data-driven decision-making.
• Integrated Care Model: The company's integrated care model fosters collaboration among providers and improves patient outcomes.
• Value-Based Care Focus: Astrana Health's focus on value-based care aligns incentives with providers and rewards them for delivering high-quality, cost-effective care.

What Does ASTH Do?

Astrana Health, Inc., formerly known as Apollo Medical Holdings, Inc., was incorporated in 1985 and rebranded in February 2024. Headquartered in Alhambra, California, the company operates as a physician-centric, technology-powered healthcare management organization. Astrana Health provides medical care services across the United States, focusing on an integrated, value-based healthcare model. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The Care Partners segment focuses on collaborating with physician groups and health plans to improve care coordination and outcomes. The Care Delivery segment provides direct medical services through its network of primary care physicians, specialists, and hospitalists. The Care Enablement segment leverages Astrana Health's proprietary population health management and healthcare delivery platform to empower providers and enhance patient care. Astrana Health serves patients covered by private or public insurance, including Medicare, Medicaid, and HMO plans, as well as non-insured patients. The company's core mission is to improve healthcare delivery through technology and a focus on value-based care.

What Products and Services Does ASTH Offer?

• Provides medical care services in the United States.
• Operates through three segments: Care Partners, Care Delivery, and Care Enablement.
• Leverages a proprietary population health management and healthcare delivery platform.
• Operates an integrated, value-based healthcare model.
• Empowers providers to deliver care to patients.
• Offers care coordination services to patients, families, and healthcare providers.
• Serves patients covered by private or public insurance, as well as non-insured patients.

How Does ASTH Make Money?

• Generates revenue through providing medical care services to patients.
• Receives payments from private and public insurance plans, including Medicare and Medicaid.
• Earns revenue from value-based care contracts, which reward providers for delivering high-quality, cost-effective care.

What Industry Does ASTH Operate In?

Astrana Health operates within the dynamic and evolving healthcare industry, characterized by increasing demand for value-based care and technology-driven solutions. The industry is experiencing a shift towards preventative care and chronic disease management, driven by an aging population and rising healthcare costs. The competitive landscape includes established healthcare providers, managed care organizations, and emerging technology companies. Astrana Health differentiates itself through its integrated care model and proprietary technology platform, positioning it to capitalize on the growing demand for efficient and effective healthcare services.

Who Are ASTH's Key Customers?

• Patients covered by private insurance plans.
• Patients covered by public insurance plans, such as Medicare and Medicaid.
• Non-insured patients.

Wall Street analysts project Astrana Health, Inc. revenue of about $3.98B for fiscal 2026, with EPS near $1.39. The estimate reflects 6 contributing analysts.

Astrana Health, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.86 places it in the grey zone, a middle ground that warrants monitoring.

Return on equity for Astrana Health, Inc. stands at 3.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.3%, showing how much profit it generates from its asset base. ASTH trades at a trailing price-to-earnings ratio of 62.59, above the Healthcare sector average of ~23x. Its free cash flow yield is 8.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.35 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.6%, the inverse of the P/E and a quick read on earnings relative to price.

Astrana Health, Inc. (ASTH) Valuation Context

Valued at $1.92B, ASTH is classified as a small-cap stock. Relative to its peer group, ASTH's quantitative score of 78/100 is roughly in line with the peer average of 71/100.

ASTH Revenue & Earnings Trend

In Q2 2026, ASTH generated $972.5M in top-line revenue, marking a sequential increase of 0.8%. The company recorded net income of $19.7M, with diluted EPS of $0.40. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this small-cap Healthcare company. Across the four most recent quarters, ASTH averaged $0.20 in diluted EPS.

Company Profile

Astrana Health, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Alhambra, US. The company is led by CEO Brandon K. Sim. ASTH has traded publicly since 2009.

ASTH Financials

ASTH Latest News

ASTH Analyst Consensus

ASTH MoonshotScore

Common Questions About ASTH (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources